German Pharmaceuticals & Biotech Strong Balance Sheet Stocks

PExA

Market Cap: €9.6m

Develops and commercializes diagnostic products in various respiratory diseases.

Merck KGaA

Market Cap: €46.2b

Operates as a science and technology company in Germany.

2invest

Market Cap: €74.4m

An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally.

Respiratorius

Market Cap: €19.4m

A research company, develops drug candidates for the treatment of cancer, chronic obstructive pulmonary disease (COPD), and asthma.

Biomark Diagnostics

Market Cap: €18.1m

Develops early-stage cancer diagnostic technology platform to detect and treat cancer.

Evotec

Market Cap: €1.1b

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

AcuCort

Market Cap: €132.5m

Develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions.

Cantourage Group

Market Cap: €42.4m

Operates as a medical cannabis company in Europe.

Heidelberg Pharma

Market Cap: €138.9m

A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, the United States, and internationally.

Apontis Pharma

Market Cap: €91.2m

Engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.

Biofrontera

Market Cap: €16.8m

A biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally.

Dextech Medical

Market Cap: €180.2m

Engages in the development of drug candidates with application in urological oncology, primarily prostate cancer.

SCHOTT Pharma KGaA

Market Cap: €3.2b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.

Liminal BioSciences

Market Cap: €11.8m

Liminal BioSciences Inc., a development stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom.

Genetic Analysis

Market Cap: €59.4m

A science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.

Darwin

Market Cap: €96.0m

Operates as a biotechnology company.

bioXXmed

Market Cap: €135.9k

An investment company, invests in biotechnology or medical technology companies with equity or debt capital.

Formycon

Market Cap: €398.3m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.

Dermapharm Holding

Market Cap: €1.7b

Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.

Medigene

Market Cap: €1.0m

A biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer.

PharmaSGP Holding

Market Cap: €352.3m

Manufactures and sells over-the-counter drugs and other healthcare products in Germany.